You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 8,491,917

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,491,917

Title:	Treatment of migraine headache with diffusion of toxin in non-muscle related areas of the head
Abstract:	A method for treating a patient with migraine headache in accordance with the present invention generally includes administering to the patient a therapeutically effective amount of a Botulinum toxin in a pharmaceutically safe form with the administration being on the trigeminal cervical system, for enabling axonal transport of the neurotoxin from distal to central sites. More specifically, the administration includes extramuscular injection of the neurotoxin over the aponeurotic fascia of the scalp for enabling the neurotoxin to diffuse into distal sensory nerves, in order to enable concentration over the occipital-parietal-frontal head region.
Inventor(s):	Bender; William J. (Beverly Hills, CA)
Assignee:
Application Number:	13/478,876
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,491,917
Patent Claims:	1. A method for treating a human patient with migraine headache, said method comprising administering to the patient a therapeutically effective amount of diluted Botulinum toxin in a pharmaceutically safe form wherein said diluted Botulinum toxin is about 4-10 cc normal saline per 100 units of Botulinum toxin, said administration comprising extramuscular injection into one or more of the frontal, parietal and occipital aponeurotic fascia in the scalp. 2. The method according to claim 1 wherein the Botulinum toxin is Botulinum toxin A. 3. The method according to claim 1 wherein the Botulinum toxin is Botulinum toxin B. 4. The method according to claim 1 wherein the Botulinum toxin is an endopeptidase derived from Botulinum toxin. 5. The method according to claim 2 wherein the Botulinum toxin A is onabotulinumtoxinA.

Details for Patent 8,491,917

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Allergan, Inc.	BOTOX COSMETIC	onabotulinumtoxina	For Injection	103000	12/09/1991	⤷ Try a Trial	2032-03-12
Allergan, Inc.	BOTOX	onabotulinumtoxina	For Injection	103000	12/09/1991	⤷ Try a Trial	2032-03-12
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.